MedTrace Logo

Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide

NCT00489645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2008-01-16

No results posted yet for this study

Summary

• To examine the influence of acute glycaemia (normoglycaemia and hyperglycaemia) on gastric emptying kinetics in patients with type 1 diabetes and non diabetic subjects when treated with subcutaneous (SC) injections of pramlintide.

Conditions

Interventions

DRUG

placebo

placebo SC during euglycemia

DRUG

pramlintide

pramlintide SC during eglycemia

DRUG

placebo

placebo during hyperglycemia

DRUG

pramlintide

pramlintide SC during hyperglycemia

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Joerg Schirra, MD · Ludwig-Maximilians-University of Munic

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-03-31
Completion
2007-04-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00489645 on ClinicalTrials.gov